NIA is India's largest insurer but continues to make high underwriting losses (1H COR: 116.4%). We also note company's competitive positioning is only weakening and thus we remain concerned of company's ability of write high quality (profitable) business in the near future. We estimate an FY22E adj. RoE of just 7.2%, and can at best assign a valuation of just 0.6x Sep-21E ABV (less 10% discount for expected 10.4% supply). Given recent run up in price, we downgrade the stock to SELL with an unchanged TP of Rs 116. While NIA reported a better than expected COR of 118.3% (-610bps YoY), high NEP meant large underwriting losses of Rs 11.0bn (+9.4% YoY). Investment income (Rs 17.1bn, 11.6% yield) and low tax rate (12.2%) ensured a high PAT of Rs 5.6bn (+59.8/99.2% YoY/QoQ). We note improvement in core ICRs but our estimates already build the same and hence remain unchanged.